UNDERWRITING AGREEMENT
Exhibit 1.1
November 19, 2007
BMO Capital Markets Corp.
As Representative of the Several Underwriters
0 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
As Representative of the Several Underwriters
0 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
NGAS Resources, Inc., a corporation organized under the laws of the Province of British
Columbia (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and
sell an aggregate of 4,200,000 shares (the “Shares”) of the Company’s common stock, no par value
per share (the “Common Stock”), to the several underwriters named in Schedule I
(collectively, the “Underwriters”), for whom BMO Capital Markets Corp., a Delaware corporation
(“BMOCM”), is acting as representative (the “Representative”).
The public offering price per share at which the Shares are initially offered and the purchase
price per share for the Shares to be paid by Underwriters shall be agreed upon by the Company and
the Representative, acting on behalf of the several Underwriters. The offering of the Shares shall
be governed by this Agreement.
The Company confirms as follows its agreement with the Representative and the several other
Underwriters:
1. Agreement to Sell and Purchase. On the basis of the representations, warranties
and agreements of the Company herein contained and subject to all the terms and conditions of this
Agreement, the Company agrees to sell to the several Underwriters and each of the several
Underwriters, severally and not jointly, agrees to purchase from the Company, at the purchase price
per share to be agreed upon by the Company and the Representative, the number of Shares set forth
opposite the name of such Underwriter in Schedule I, plus such additional number of Shares
which such Underwriter may become obligated to purchase pursuant to Section 8 hereof.
2. Delivery and Payment.
(a) Closing. Delivery of the Shares shall be made to the Representative through the
facilities of the Depository Trust Company (“DTC”) for the respective accounts of the Underwriters
against payment of the purchase price by wire transfer of immediately available funds to the order
of the Company at the offices of Xxxxx & Xxxxxxxxxxx, 000 Xxxxx Xxxxxx, Xxxxx 00X, Xxx Xxxx, Xxx
Xxxx (or such other place as may be agreed upon among the Representative and the Company). Such
payment shall be made at 10:00 a.m., New York City time, on the third business day (the fourth
business day, should the offering be priced after 4:00 p.m., New York City time) after the date on
which the first bona fide offering of the Shares to the public is made by the Underwriters or at
such time on such other date, not later than ten business days after such date, as may be agreed
upon by the Company and the Representative (such date is hereinafter referred to as the “Closing
Date”).
(b) Certificates. Certificates evidencing the Shares shall be in definitive form and shall be
registered in such names and in such denominations as the Representative shall request at least two
business days prior to the Closing Date by written notice to the Company. Electronic transfer of
Shares shall be made at the time of purchase in such names and in such denominations as the
Representative shall specify.
(c) Tax Stamps. The cost of original issue tax stamps, if any, in connection with the
issuance and delivery of the Shares by the Company to the respective Underwriters shall be borne by
the Company. The Company shall pay and hold each Underwriter and any subsequent holder of the
Shares harmless from any and all liabilities with respect to or resulting from any failure or delay
in paying Federal and state stamp and other transfer taxes, if any, which may be payable or
determined to be payable in connection with the original issuance or sale to such Underwriter of
the Shares.
3. Representations and Warranties of the Company. The Company represents and warrants
to, and covenants with, each Underwriter as follows:
(a) Compliance with Registration Requirements. The Company meets the requirements for use of
Form S-3 and a registration statement on Form S-3 (Registration No. 333-144417) relating to the
Shares, including a preliminary prospectus and such amendments to such registration statement as
may have been required to the date of this Agreement, has been prepared by the Company under the
provisions of the Securities Act of 1933, as amended (the “Act”), and the rules and regulations
(collectively referred to as the “Rules and Regulations”) of the Securities and Exchange Commission
(the “Commission”) thereunder, and has been filed with the Commission. Copies of such registration
statement and of each amendment thereto, if any, including the related preliminary prospectuses,
heretofore filed by the Company with the Commission have been delivered to the Representative. The
term “preliminary prospectus” as used herein means a preliminary prospectus as contemplated by Rule
430, Rule 430A or Rule 430B, of the Rules and Regulations included at any time as part of, or
deemed to be part of or included in, the registration statement. The term “Registration Statement”
means the registration statement as amended at the time it becomes or became effective, including
financial statements and all exhibits and any information deemed to be included therein by Rule
430A, Rule 430B or Rule 430C of the Rules and Regulations, as applicable. If the Company files a
registration statement to register a portion of the Shares and relies on Rule 462(b) of the Rules
and Regulations for such registration statement to become effective upon filing with the Commission
(the “Rule 462 Registration Statement”), then any reference to the “Registration Statement” shall
be deemed to include the Rule 462 Registration Statement, as amended from time to time. The term
“Prospectus” means the final prospectus in connection with this offering as first filed with the
Commission pursuant to Rule 424(b) of the Rules and Regulations or, if no such filing is required,
the form of final prospectus included in the Registration Statement at the effective date. Any
reference herein to the Registration Statement, any preliminary prospectus or the Prospectus shall
be deemed to refer to and include the documents incorporated by reference therein pursuant to Item
12 of Form S-3 which were filed under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or in respect of the Registration Statement, other information deemed by the Rules
and Regulations to be a part of or included therein, on or before the initial effective date or the
date of such preliminary prospectus or the Prospectus, as the case may be. Any reference herein to
the terms “amend,” “amendment” or “supplement” with respect to the Registration Statement, any
preliminary prospectus or the Prospectus shall be deemed to refer to and include the filing of any
document under the Exchange Act which is incorporated by reference therein, or in respect of the
Registration Statement, such other information deemed by the Rules and Regulations to be a part of
or included therein, after the initial effective date, or the date of the preliminary prospectus or
the Prospectus, as the case may be.
(b) Effectiveness of Registration. The Registration Statement, any Rule 462 Registration
Statement and any post-effective amendment thereto have been declared effective by the Commission
under the Act or have become effective pursuant to Rule 462 under the Rules and Regulations. The
Company has responded to all requests, if any, of the Commission for additional or supplemental
information. No stop order suspending the effectiveness of the Registration Statement or any Rule
462 Registration Statement is in effect and no proceedings for such purpose have been instituted or
are pending or, to the best knowledge of the Company, are contemplated or threatened by the
Commission.
(c) Accuracy of Registration Statement. Each of the Registration Statement, any Rule 462(b)
Registration Statement and any post-effective amendment thereto, at the time it became effective
and at all subsequent times, complied and will comply in all material respects with the Act and the
Rules and Regulations, and did not and will not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in order to make the
statements therein not misleading. The Prospectus, as amended or supplemented, as of its date and
at all subsequent times, complied and will comply in all material respects with the Act and the
Rules and Regulations, and did not or will not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements therein not misleading, in the light
of the circumstances under which they were made. Each preliminary prospectus (including the
preliminary prospectus or prospectuses filed as part of the Registration Statement or any amendment
thereto) complied when so filed in all material respects with the Rules and Regulations and each
preliminary prospectus and the Prospectus delivered to the Underwriters for use in connection with
this offering is identical to the electronically transmitted copies thereof filed with the
Commission on XXXXX, except to the extent permitted by Regulation S-T. The foregoing
representations and warranties in this Section 3(c) do not apply to any statements or omissions
made in reliance on and in conformity with information relating to any Underwriter furnished in
writing to the Company by the Representative specifically for inclusion in the Registration
Statement or Prospectus or any amendment or supplement thereto. For all purposes of this
Agreement, the amounts of the selling concession and reallowance set forth in the Prospectus
constitute the only information relating to any Underwriter furnished in writing to the Company by
the Representative specifically for inclusion in the preliminary prospectus, the Registration
Statement or the Prospectus.
2
(d) Documents Incorporated by Reference. The documents incorporated or deemed to be
incorporated by reference in the Prospectus, at the time they were or hereafter are filed with the
Commission, conformed and will conform in all material respects to the requirements of the Exchange
Act, and, when read together with the other information in the Prospectus, at the time the
Registration Statement and any amendments thereto become effective and at the Closing Date, will
not contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading.
(e) Company Not Ineligible Issuer. (i) At the earliest time after the filing of the
Registration Statement relating to the Shares that the Company or another offering participant made
a bona fide offer (within the meaning of Rule 164(h)(2)) of the Rules and Regulations and (ii) as
of the date of the execution and delivery of this Agreement (with such date being used as the
determination date for purposes of this clause (ii)), the Company was not and is not an “ineligible
issuer” (as defined in Rule 405 of the Rules and Regulations).
(f) Disclosure at the Time of Sale. As of the Applicable Time, neither (i) (A) the Issuer
General Use Free Writing Prospectus(es) (as defined below) issued at or prior to the Applicable
Time, (B) the preliminary prospectus(es) related to this offering and (C) the information contained
on Schedule II hereto, all considered together (collectively, the “General Disclosure
Package”), nor (ii) any individual Issuer Limited Use Free Writing Prospectus, when considered
together with the General Disclosure Package, included any untrue statement of a material fact or
omitted to state any material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading. The preceding sentence does not
apply to statements in or omissions from the General Disclosure Package based upon and in
conformity with written information furnished to the Company by any Underwriter through the
Representative specifically for use therein, it being understood and agreed that the only such
information furnished by or on behalf of any Underwriter consists of the information described as
such in Section 3(c) hereof.
As used in this subsection and elsewhere in this Agreement:
“Applicable Time” means 5:00 p.m., New York City time, on November 19, 2007, or such other
time as agreed by the Company and the Representative.
“Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in
Rule 433 of the Rules and Regulations, relating to the Shares that (i) is required to be filed with
the Commission by the Company, (ii) is a “road show that is a written communication” within the
meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission or (iii) is
exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Shares or
of the offering that does not reflect the final terms, in each case in the form filed or required
to be filed with the Commission or, if not required to be filed, in the form retained in the
Company’s records pursuant to Rule 433(g).
“Issuer General Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is
intended for general distribution to prospective investors, as evidenced by its being specified in
Schedule III hereto.
“Issuer Limited Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is
not an Issuer General Use Free Writing Prospectus.
(g) Issuer Free Writing Prospectuses. Each Issuer Free Writing Prospectus does not include
any information that conflicts with the information contained in the Registration Statement,
including any document incorporated by reference therein and any information in a preliminary
prospectus supplement deemed to be a part thereof that has not been superseded or modified. The
foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing
Prospectus based upon and in conformity with written information furnished to the Company by any
Underwriter through the Representative specifically for use therein, it being understood and agreed
that the only such information furnished by any Underwriter consists of the information described
as such in Section 3(c) hereof. If at any time following the issuance of an Issuer Free Writing
Prospectus there occurred or occurs an event or development as a result of which such Issuer Free
Writing Prospectus conflicted or would conflict with the information contained in the Registration
Statement relating to the Shares or included or would include an untrue statement of material fact
or omitted or would omit to state a material fact necessary in order to make the statements
therein, in light of the circumstances prevailing at that subsequent time, not misleading, the
Company has promptly notified or will promptly notify the Representative and has promptly amended
or will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to
eliminate or correct such conflict, untrue statement, or omission.
3
(h) Distribution of Offering Material by the Company. The Company has not distributed and
will not distribute, prior to the later of the Closing Date and the completion of the Underwriters’
distribution of the Shares, any offering material in connection with the offering or sale of the
Shares other than the Registration Statement, the preliminary prospectus, the Permitted Free
Writing Prospectuses reviewed and consented to by the Representative and included in Schedule
III hereto, and the Prospectus.
(i) Due Incorporation; Subsidiaries.
(i) The Company is, and at the Closing Date will be, a corporation duly organized, validly
existing and in good standing under the laws of its jurisdiction of incorporation. The Company
has, and at the Closing Date will have, full power and authority to conduct all the activities
conducted by it, to own or lease all the assets owned or leased by it and to conduct its business
as described in the Registration Statement and the Prospectus. The Company is, and at the Closing
Date will be, duly licensed or qualified to do business in and in good standing as a foreign
corporation in all jurisdictions in which the nature of the activities conducted by it or the
character of the assets owned or leased by it makes such licensing or qualification necessary.
(ii) The only significant subsidiaries (as defined in the Rules and Regulations) of the
Company are the subsidiaries listed on Schedule IV hereto (the “Subsidiaries”). The
Subsidiaries are, and at the Closing Date will be, duly organized, validly existing and in good
standing under the laws of their respective jurisdictions of organization. The Subsidiaries have,
and at the Closing Date will have, full power and authority to conduct all the activities conducted
by them, to own or lease all the assets owned or leased by them and to conduct their business as
described in the Registration Statement and the Prospectus. The Subsidiaries are, and at the
Closing Date will be, duly licensed or qualified to do business in and in good standing as foreign
entities in all jurisdictions in which the nature of the activities conducted by them or the
character of the assets owned or leased by them makes such licensing or qualification necessary.
All of the outstanding shares of capital stock of the Subsidiaries have been duly authorized and
validly issued, and are fully paid and non-assessable and are owned by the Company free and clear
of all liens, encumbrances and claims whatsoever. Except for the stock of the Subsidiaries and as
disclosed in the Registration Statement, the Company does not own, and at the Closing Date will not
own, directly or indirectly, any shares of stock or any other equity or long-term debt securities
of any corporation or have any equity interest in any firm, partnership, joint venture, association
or other entity. Complete and correct copies of the certificate of incorporation, the by-laws and
all other applicable governing documents of the Company and the Subsidiaries and all amendments
thereto have been delivered to the Representative, and no changes therein will be made subsequent
to the date hereof and prior to the Closing Date.
(j) Authorization of Shares. The authorized, issued and outstanding capital stock of the
Company is as set forth in the Registration Statement and the Prospectus under the caption
“Capitalization.” The outstanding shares of Common Stock and any other outstanding capital stock
of the Company have been, and the Shares to be issued and sold by the Company upon such issuance in
accordance with this Agreement will be, duly authorized, validly issued, fully paid and
non-assessable and will not be subject to any preemptive, first refusal, or similar right. The
description of the Common Stock included or incorporated by reference in the Registration Statement
and the Prospectus is now, and at the Closing Date will be, complete and accurate in all material
respects. Except as set forth or incorporated by reference in the Prospectus, the Company does not
have outstanding, and at the Closing Date will not have outstanding, any options to purchase, or
any rights or warrants to subscribe for, or any securities or obligations convertible into, or any
contracts or commitments to issue or sell, any shares of capital stock of the Company or of any
Subsidiaries or any such warrants, convertible securities or obligations. Upon the issuance and
delivery pursuant to the terms of this Agreement, the Underwriters will acquire good and marketable
title to the Shares, free and clear of any liens, charge, claim, encumbrance, pledge, security
interest, defect or other restriction or equity of any kind whatsoever.
(k) Financial Statements. (i) The financial statements and schedules included or incorporated
by reference in the Registration Statement or the Prospectus present fairly the consolidated
financial condition of the Company and the Subsidiaries as of the respective dates thereof and the
consolidated results of operations and cash flows of the Company and the Subsidiaries for the
respective periods covered thereby, all in conformity with generally accepted accounting principles
applied on a consistent basis throughout the entire period involved, except as otherwise disclosed
in the Prospectus. No other financial statements, schedules or “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission) of the
Company are required by the Act, the Exchange Act and the Rules and Regulations of the Exchange Act
or the Rules and Regulations to be included in the Registration Statement or the Prospectus.
4
(ii) Hall, Xxxxxxx & Company LLP (the “Accountants”) who have reported on such financial
statements and schedules for the year ended December 31, 2006, are independent accountants with
respect to the Company as required by the Act and the Rules and Regulations and by Rule 3600T of
the Public Accounting Oversight Board. Except as described in the Prospectus and as preapproved in
accordance with the requirements set forth in Section 10A of the Exchange Act, Hall, Xxxxxxx &
Company LLP has not engaged in any “prohibited activities” (as defined in Section 10A of the
Exchange Act) on behalf of the Company. The statements included in the Registration Statement with
respect to the Accountants pursuant to Rule 509 of Regulation S-K of the Rules and Regulations are
true and correct in all material respects.
(l) Accounting System. The Company and its Subsidiaries (i) make and keep accurate books and
records and (ii) maintain internal accounting controls that provide reasonable assurance that: (A)
transactions are executed in accordance with management’s general or specific authorization; (B)
transactions are recorded as necessary to permit preparation of financial statements in conformity
with generally accepted accounting principles and to maintain accountability for assets; (C) access
to assets is permitted only in accordance with management’s general or specific authorization; and
(D) the recorded accountability for assets is compared with existing assets at reasonable intervals
and appropriate action is taken with respect to any differences.
(m) No Material Adverse Changes. Since the respective dates as of which information is given
in the Registration Statement and the Prospectus and prior to the Closing Date, except as set forth
or incorporated by reference in the Prospectus, (i) there has not been and will not have been a
material adverse change in the business, properties, business prospects, condition (financial or
otherwise) or results of operations of each of the Company and the Subsidiaries, taken as a whole,
arising for any reason whatsoever (a “Material Adverse Change”) or a Material Adverse Change in the
capitalization of the Company, (ii) the Company has incurred, nor will it incur, any material
liabilities or obligations, direct or contingent, nor has it entered into, nor will it enter into,
any material transactions not in the ordinary course of business, other than pursuant to this
Agreement and the transactions referred to herein, and (iii) the Company has not and will not have
paid or declared any dividends or other distributions of any kind on any class of its capital
stock.
(n) Investment Company. The Company is not an “investment company” or an “affiliated person”
of, or “promoter” or “principal underwriter” for, an “investment company,” as such terms are
defined in the Investment Company Act of 1940, as amended.
(o) Litigation. Except as set forth or incorporated by reference in the Prospectus, there are
no actions, suits or proceedings pending, or to the Company’s knowledge, threatened against or
affecting, the Company or any of the Subsidiaries or any of their respective officers in their
capacity as such, before or by any federal or state court, commission, regulatory body including
FINRA and the NASDAQ Stock Market, Inc. (“NASDAQ”), administrative agency or other governmental
body, domestic or foreign, wherein an unfavorable ruling, decision or finding would reasonably be
expected to have a material adverse effect on the business, properties, business prospects,
condition (financial or otherwise) or results of operations of the Company and the Subsidiaries,
taken as a whole (a “Material Adverse Effect”). Neither the Company nor any of the Subsidiaries
has received any notice of proceedings relating to the revocation or modification of any
authorization, approval, order, license, certificate, franchise or permit. There are no pending
investigations known to the Company involving the Company or any of the Subsidiaries by any
governmental agency having jurisdiction over the Company or any of the Subsidiaries or their
respective businesses or operations.
(p) Necessary Licenses, Compliance with Laws and Regulations and Performance of Obligations
and Contracts. Each of the Company and the Subsidiaries has, and at the Closing Date will have,
(i) all governmental and other regulatory licenses, permits, consents, orders, approvals and other
authorizations necessary to carry on its business as contemplated in the Prospectus, (ii) complied
in all material respects with all laws, regulations and orders applicable to it or its business and
(iii) performed all obligations required to be performed by it, and is not, and at the Closing Date
will not be, in default under any indenture, mortgage, deed of trust, voting trust agreement, loan
agreement, bond, debenture, note agreement, lease or other agreement or instrument (individually, a
“Contract” and collectively, “Contracts”) to which it is a party or by which its property is bound
or affected. To the best knowledge of the Company, no other party under any Contract to which it
or the Subsidiaries is a party is in
5
default in any respect thereunder or has given written, or to the knowledge of the officers
and directors of the Company oral, notice to the Company, the Subsidiaries or any of their
respective officers or directors of such other party’s intention to terminate, cancel or refuse to
renew any Contract. Each of the Company and the Subsidiaries is not now, and at the Closing Date
will not be, in violation of any provision of its certificate of incorporation, by-laws or other
applicable governing documents. The disclosures included or incorporated by reference in the
Prospectus and the Registration Statement concerning the effects of Federal, state, local and
foreign laws, rules and regulations on the business of each of the Company and the Subsidiaries as
currently conducted and as proposed to be conducted are correct in all material respects and do not
omit to state a material fact required to be stated therein or necessary to make the statements
contained therein not misleading, in light of the circumstances under which they were made.
(q) No Consent of Governmental Body Needed. No consent, approval, authorization or order of,
or any filing or declaration with, any court or governmental agency or body is required in
connection with the authorization, issuance, transfer, sale or delivery of the Shares by the
Company, in connection with the execution, delivery and performance of this Agreement by the
Company or in connection with the taking by the Company of any action contemplated hereby, except
as have been obtained under the Act and such as may be required under state securities or Blue Sky
laws or the by-laws and rules of the Financial Industry Regulatory Authority (“FINRA”) in
connection with the purchase and distribution by the Underwriters of the Shares to be sold by the
Company.
(r) Agreement Duly Authorized and No Breach of Obligations or Charter. The Company has full
corporate power and authority to enter into this Agreement. This Agreement has been duly
authorized, executed and delivered by the Company and constitutes a valid and binding agreement of
the Company enforceable against the Company in accordance with the terms hereof, except as the
enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or
other similar laws relating to or affecting creditors’ rights generally or general equitable
principles. The execution and delivery by the Company of this Agreement and the performance of
this Agreement, the consummation of the transactions contemplated hereby, and the application of
the net proceeds from the offering and sale of the Shares to be sold by the Company in the manner
set forth in the Prospectus under “Use of Proceeds” do not and will not (i) violate the certificate
of incorporation or by-laws of the Company or applicable governing documents of any of the
Subsidiaries or (ii) result in the creation or imposition of any lien, charge or encumbrance upon
any of the assets of the Company or any of its Subsidiaries pursuant to the terms or provisions of,
or result in a breach or violation of any of the terms or provisions of, or constitute a default
under, or give any other party a right to terminate any of its obligations under, or result in the
acceleration of any obligation under any Contract to which the Company or any of the Subsidiaries
is a party or by which the Company or any of the Subsidiaries or any of its properties is bound or
affected, or violate or conflict with any judgment, ruling, decree, order, statute, rule or
regulation of any court or other governmental agency or body applicable to the business or
properties of the Company or any of the Subsidiaries.
(s) Title to Property. The Company and each of the Subsidiaries has good and marketable title
to all properties and assets described in the Prospectus or in documents incorporated by reference
in the Prospectus as being owned respectively by it, free and clear of all liens, charges,
encumbrances or restrictions, except as set forth or incorporated by reference in the Prospectus or
are not material to the business of the Company or the Subsidiaries. Each of the Company and the
Subsidiaries has valid, subsisting and enforceable leases or farmouts for the properties described
or incorporated by reference in the Prospectus as leased or controlled by it, with such exceptions
as are not material and do not materially interfere with the use made and proposed to be made of
such properties by the Company.
(t) Documents Described in Registration Statement. There is no document or Contract of a
character required to be described or incorporated by reference in the Registration Statement or
the Prospectus or to be filed as an exhibit to the Registration Statement that is not described or
filed as required. All such documents and Contracts described or incorporated by reference in the
Registration Statement or the Prospectus or filed as an exhibit to the Registration Statement were
duly authorized, executed and delivered by the Company or Subsidiaries, constitutes valid and
binding agreements of the Company or such Subsidiaries and are enforceable against the Company or
such Subsidiaries in accordance with the terms thereof.
(u) No Untrue Statement; Statistical and Market Data. No statement, representation, warranty
or covenant made by the Company in this Agreement or made in any certificate or document required
by this Agreement to be delivered to Representative was or will be, when made, inaccurate, untrue
or incorrect. All
6
statistical or market-related data included in the Registration Statement or the Prospectus
are based on or derived from sources that the Company believes to be reliable and accurate, and the
Company has obtained the written consent to the use of such data from such sources to the extent
required.
(v) No Price Stabilization or Manipulation. Neither the Company nor any of its directors,
officers or controlling persons has taken, directly or indirectly, any action intended to cause or
result in, or which might reasonably be expected to cause or result in, or which has constituted,
stabilization or manipulation, under the Act or otherwise, of the price of any security of the
Company to facilitate the sale or resale of the Shares.
(w) No Registration Rights. No holder of securities of the Company has rights to register any
securities of the Company because of the filing of the Registration Statement, the Prospectus or
the offering of the Shares, except for rights that have been duly waived by such holder, have
expired or have been fulfilled by registration prior to the date of this Agreement.
(x) Stock Exchange Listing. Prior to the Closing Date, the Shares will be duly authorized
for listing or quotation on the NASDAQ Global Select Market, subject only to notice of issuance.
(y) Labor Matters. The Company is not involved in any material labor dispute nor, to the
knowledge of the Company, is any such dispute threatened.
(z) No Unlawful Contributions or Payments. Neither the Company nor any of the Subsidiaries
nor, to the best of the Company’s knowledge, any of its/their respective officers, directors,
employees or agents, have made any contribution or other payment to any official of, or candidate
for, any federal, state or foreign office in violation of any law or of the character required to
be disclosed in the Prospectus.
(aa) Taxes. The Company and each of the Subsidiaries has filed all federal, state and foreign
income and franchise tax returns and has paid all taxes required to be filed or paid by it and, if
due and payable, any related or similar assessment, fine or penalty levied against it. The Company
has made adequate charges, accruals and reserves in the applicable financial statements referred to
in Section 3(k) above in respect of all material federal, state and foreign income and franchise
taxes for all periods as to which the tax liability of the Company has not been finally determined.
(bb) Insurance. The Company and each of the Subsidiaries carries, or is covered by, insurance
in such amounts and covering such risks as it believes is adequate for the conduct of its business
and the value of its properties and is customary for companies engaged in similar industries.
(cc) Defined Benefit Plans. Neither the Company nor any of the Subsidiaries has maintained or
contributed to a defined benefit plan as defined in Section 3(35) of the Employee Retirement Income
Security Act of 1974, as amended (“ERISA”). No plan maintained or contributed to by the Company
that is subject to ERISA (an “ERISA Plan”) (or any trust created thereunder) has engaged in a
“prohibited transaction” within the meaning of Section 406 of ERISA or Section 4975 of the Code
that could subject the Company or any of the Subsidiaries to any material tax penalty on prohibited
transactions and that has not adequately been corrected. Each ERISA Plan is in compliance in all
material respects with all reporting, disclosure and other requirements of the Code and ERISA as
they relate to such ERISA Plan, except for any noncompliance which would not result in the
imposition of a material tax or monetary penalty. With respect to each ERISA Plan that is intended
to be “qualified” within the meaning of Section 401(a) of the Code, either (i) a determination
letter has been issued by the Internal Revenue Service stating that such ERISA Plan and the
attendant trust are qualified thereunder, or (ii) the remedial amendment period under Section
401(b) of the Code with respect to the establishment of such ERISA Plan has not ended and a
determination letter application will be filed with respect to such ERISA Plan prior to the end of
such remedial amendment period. Neither the Company nor any of the Subsidiaries has ever
completely or partially withdrawn from a “multiemployer plan,” as defined in Section 3(37) of
ERISA.
(dd) Intellectual Property. Except as set forth or incorporated by reference in the
Prospectus, each of the Company and the Subsidiaries owns, is licensed or otherwise has adequate
rights to use Company technology (including but not limited to patented, patentable and unpatented
inventions and unpatentable proprietary or confidential information, systems or procedures),
designs, processes, trademarks, trade secrets, know how, copyrights and other works of authorship,
computer programs and technical data and information (collectively, the “Intellectual Property”)
that are or could reasonably be expected to be material to its business as currently conducted
7
or proposed to be conducted or to the development, manufacture, operation and sale of any
products and services sold or proposed to be sold by any of the Company or any of the Subsidiaries.
Neither the Company nor any of the Subsidiaries has received any threat of or notice of
infringement of or conflict with asserted rights of others with respect to any Intellectual
Property. Except as set forth or incorporated by reference in the Prospectus, neither the Company
nor any of the Subsidiaries are obligated or under any liability whatsoever to make any material
payment by way of royalties, fees or otherwise to any owner or licensee of, or other claimant to,
any Intellectual Property, with respect to the use thereof or in connection with the conduct of
their respective businesses or otherwise.
(ee) Trademarks. The Company and each of the Subsidiaries own, or are licensed or otherwise
have the full exclusive right to use, all material trademarks and trade names that are used in or
reasonably necessary for the conduct of their respective businesses as described in the Prospectus.
Neither the Company nor any of the Subsidiaries has received any notice of infringement of or
conflict with asserted rights of others with respect to any such trademarks or trade names, or
challenging or questioning the validity or effectiveness of any such trademark or trade name. The
use, in connection with the business and operations of the Company and each of the Subsidiaries of
such trademarks and trade names does not, to the Company’s knowledge, infringe on the rights of any
person. Except as set forth in the Prospectus, the Company and its Subsidiaries are not obligated
or under any liability whatsoever to make any payment by way of royalties, fees or otherwise to any
owner or licensee of, or other claimant to, any trademark, service xxxx or trade name with respect
to the use thereof or in connection with the conduct of their respective businesses or otherwise.
(ff) Protection of Intellectual Property. Each of the Company and the Subsidiaries has taken
reasonable security measures to protect the secrecy, confidentiality and value of all their
Intellectual Property in all material aspects, including, but not limited to complying with all
duty of disclosure requirements before the U.S. Patent and Trademark Office and any other non-U.S.
Patent Offices as appropriate, and has no reason to believe that such Intellectual Property is not
or, if not yet patented or registered, would not be, valid and enforceable against an unauthorized
user.
(gg) Related Party Transactions. There are no business relationships or related party
transactions involving the Company or any other person required to be described in the Prospectus
that have not been described or incorporated therein by reference. No relationship, direct or
indirect, exists between or among the Company or any Subsidiary on the one hand, and the directors,
officers, stockholders, customers or suppliers of the Company on the other hand, that is required
to be described in the Prospectus and that is not so described or incorporated therein by
reference. The Company has provided you true, correct and complete copies of all documentation
pertaining to any extension of credit in the form of a personal loan made, directly or indirectly,
by the Company to any director or executive officer of the Company, or to any family member or
affiliate of any director or executive officer of the Company; and since January 1, 2004, the
Company has not, directly or indirectly, including through any Subsidiary: (i) extended or
maintained credit, arranged to extend credit, or renewed any extension of credit, in the form of a
personal loan, to or for any director or executive officer of the Company, or to or for any family
member or affiliate of any director or executive officer of the Company; or (ii) made any material
modification, including any renewal thereof, to any term of any personal loan to any director or
executive officer of the Company, or any family member or affiliate of any director or executive
officer, which loan was outstanding on January 1, 2004.
(hh) Environmental Matters. The Company (i) is in compliance with any and all applicable
federal, state and local laws and regulations relating to the protection of human health and
safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants
(collectively, “Environmental Laws”), (ii) has received all permits, licenses or other approvals
required of it under applicable Environmental Laws to conduct its businesses and (iii) is in
compliance with all terms and conditions of any such permit, license or approval.
(ii) Controls and Procedures.
(i) Disclosure Controls and Procedures. The Company has established and maintains disclosure
controls and procedures (as such term is defined in Rule 13a-15 and 15d-15 under the Exchange Act),
that (A) are designed to ensure that material information relating to the Company, including its
consolidated subsidiaries, is made known to the Company’s principal executive officer and its
principal financial officer by others within those entities, particularly during the periods in
which the periodic reports required under the Exchange Act are being prepared; (B) provide for the
periodic evaluation of the effectiveness of such disclosure controls and procedures as of the end
of the period covered by the Company’s most recent annual or quarterly report filed with the Commission; and (C) are effective in all material respects to perform the
functions for which they were established.
8
(ii) Internal Control Over Financial Reporting and Internal Accounting Controls. The Company
maintains (i) effective internal control over financial reporting as defined in Rules 13a-15 and
15d-15 under the Exchange Act, and (ii) a system of internal accounting controls sufficient to
provide reasonable assurance that (A) transactions are executed in accordance with management’s
general or specific authorizations; (B) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally accepted accounting principles and
to maintain asset accountability; (C) access to assets is permitted only in accordance with
management’s general or specific authorization; and (D) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with
respect to any differences.
(iii) No Material Weakness in Internal Controls. Except as disclosed in the General
Disclosure Package and the Prospectus, or in any document incorporated by reference therein, since
the end of the Company’s most recent audited fiscal year, there has been (i) no material weakness
in the Company’s internal control over financial reporting (whether or not remediated) and (ii) no
change in the Company’s internal control over financial reporting that has materially affected, or
is reasonably likely to materially affect, the Company’s internal control over financial reporting.
(iv) The Company is not aware of (A) any significant deficiency in the design or operation of
its internal control over financial reporting which are reasonably likely to adversely affect the
Company’s ability to record, process, summarize and report financial data or any material
weaknesses in internal controls, except as disclosed in the General Disclosure Package and the
Prospectus, or in any document incorporated by reference therein, since the end of the Company’s
most recent audited fiscal year; or (B) any fraud, whether or not material, that involves
management or other employees who have a significant role in the Company’s internal controls.
(jj) Off-Balance Sheet Transactions. Except as described in the General Disclosure Package
and the Prospectus, there are no material off-balance sheet transactions (including, without
limitation, transactions related to, and the existence of, “variable interest entities” within the
meaning of Financial Accounting Standards Board Interpretation No. 46), arrangements, obligations
(including contingent obligations), or any other relationships with unconsolidated entities or
other persons, that may have a material current or future effect on the Company’s financial
condition, changes in financial condition, results of operations, liquidity, capital expenditures,
capital resources, or significant components of revenues or expenses.
(kk) Audit Committee. The Company’s Board of Directors has validly appointed an audit
committee whose composition satisfies the requirements of Rule 4350(d)(2) of the Rules of NASDAQ
and Section 10A-3 of the Exchange Act and the Board of Directors and/or the audit committee has
adopted a charter that satisfies the requirements of Rule 4350(d)(1) of the Rules of NASDAQ and
Section 10A-3 of the Exchange Act. The audit committee has reviewed the adequacy of its charter
within the past twelve months. Neither the Board of Directors nor the audit committee has been
informed, nor is any director of the Company aware, of (i) any significant deficiencies in the
design or operation of the Company’s internal controls that could adversely affect the Company’s
ability to record, process, summarize and report financial data or any material weakness in the
Company’s internal controls; or (ii) any fraud, whether or not material, that involves management
or other employees of the Company who have a significant role in the Company’s internal controls.
(ll) Xxxxxxxx-Xxxxx. The Company is, and after giving effect to the offering and sale of the
Shares will be, in compliance in all material respects with all applicable effective provisions of
the Xxxxxxxx-Xxxxx Act of 2002 and the rules and regulations of the Commission promulgated
thereunder.
(mm) FINRA Review. To enable the underwriters to rely on Rule 2710(b)(7)(C)(i) of FINRA, the
Company represents that the Company (i) has a non-affiliate, public common equity float of at least
$150 million or a non-affiliate, public common equity float of at least $100 million and annual
trading volume of at least three million shares and (ii) has been subject to the Exchange Act
reporting requirements for a period of at least 36 months.
9
4. Agreements of the Company. The Company agrees with each Underwriter as follows:
(a) Amendments and Supplements to Registration Statement. The Company shall not, either prior
to any effective date or thereafter during such period as the Prospectus is required by law to be
delivered (the “Prospectus Delivery Period”) in connection with sales of the Shares by an
Underwriter or dealer, amend or supplement to the Registration Statement, the General Disclosure
Package or the Prospectus, unless a copy of such amendment or supplement thereof shall first have
been submitted to the Representative within a reasonable period of time prior to the filing or, if
no filing is required, the use thereof and the Representative shall not have objected thereto in
good faith.
(b) Amendments and Supplements to the Registration Statement, the General Disclosure Package,
and the Prospectus and Other Securities Act Matters. If, during the Prospectus Delivery Period,
any event or development shall occur or condition exist as a result of which the General Disclosure
Package or the Prospectus as then amended or supplemented would include any untrue statement of a
material fact or omit to state any material fact necessary in order to make the statements therein,
in the light of the circumstances then prevailing or under which they were made, as the case may
be, not misleading, or if it shall be necessary to amend or supplement the General Disclosure
Package or the Prospectus, or to file under the Exchange Act any document incorporated by reference
in the General Disclosure Package or the Prospectus, in order to make the statements therein, in
the light of the circumstances then prevailing or under which they were made, as the case may be,
not misleading, or if in the opinion of the Representative it is otherwise necessary to amend or
supplement the Registration Statement, the General Disclosure Package or the Prospectus, or to file
under the Exchange Act any document incorporated by reference in the General Disclosure Package or
the Prospectus, or to file a new registration statement containing the Prospectus, in order to
comply with law, including in connection with the delivery of the Prospectus, the Company agrees to
(i) promptly notify the Representatives of any such event or condition and (ii) promptly prepare
(subject to Section 4(a) and (g) hereof), file with the Commission (and use its best efforts to
have any amendment to the Registration Statement or any new registration statement to be declared
effective) and furnish at its own expense to the Underwriters and to dealers, amendments or
supplements to the Registration Statement, the General Disclosure Package or the Prospectus, or any
new registration statement, necessary in order to make the statements in the General Disclosure
Package or the Prospectus as so amended or supplemented, in the light of the circumstances then
prevailing or under which they were made, as the case may be, not misleading or so that the
Registration Statement, the General Disclosure Package or the Prospectus, as amended or
supplemented, will comply with law.
(c) Notifications to the Representative. The Company shall use its best efforts to cause the
Registration Statements to become effective, and shall notify the Representative promptly, and
shall confirm such advice in writing, (i) when any post-effective amendment to the Registration
Statement has become effective and when any post-effective amendment thereto becomes effective,
(ii) of any request by the Commission for amendments or supplements to the Registration Statement
or the Prospectus or for additional information, (iii) of the commencement by the Commission or by
any state securities commission of any proceedings for the suspension of the qualification of any
of the Shares for offering or sale in any jurisdiction or of the initiation, or the threatening, of
any proceeding for that purpose, including, without limitation, the issuance by the Commission of
any stop order suspending the effectiveness of the Registration Statement or the initiation of any
proceedings for that purpose or the threat thereof, (iv) of the happening of any event during the
period mentioned in the second sentence of Section 4(f) hereof that in the judgment of the Company
makes any statement made in the Registration Statement or the Prospectus untrue or that requires
the making of any changes in the Registration Statement or the Prospectus in order to make the
statements therein, in light of the circumstances in which they are made, not misleading and (v) of
receipt by the Company or any representative of the Company of any other communication from the
Commission relating to the Company, the Registration Statement, any preliminary prospectus or the
Prospectus. If at any time the Commission shall issue any order suspending the effectiveness of
the Registration Statement, the Company shall use best efforts to obtain the withdrawal of such
order at the earliest possible moment. The Company shall use its best efforts to comply with the
provisions of and make all requisite filings with the Commission pursuant to Rules 430A, 430B, 430C
or 462(b) of the Rules and Regulations and to notify the Representative promptly of all such
filings.
(d) Executed Registration Statements. The Company shall furnish to the Representative,
without charge, for transmittal to each of the other Underwriters, two signed copies of the
Registration Statement and of any post-effective amendment thereto, including financial statements
and schedules, and all exhibits thereto (including any document filed under the Exchange Act and
deemed to be incorporated by reference into the Prospectus), and shall furnish to the
Representative, without charge, for transmittal to each of the other Underwriters, a copy of the Registration Statement and any post-effective amendment thereto,
including financial statements and schedules but without exhibits.
10
(e) Undertakings. The Company shall comply with all the provisions of any undertakings
contained and required to be contained in the Registration Statement.
(f) Prospectus. Promptly after the effective date of the Registration Statement, and
thereafter from time to time, the Company shall deliver to each of the Underwriters, without
charge, as many copies of the Prospectus and any amendment or supplement thereto as the
Representative may reasonably request. The Company consents to the use of the Prospectus and any
amendment or supplement thereto by the Underwriters and by all dealers to whom the Shares may be
sold, both in connection with the offering or sale of the Shares and for any period of time
thereafter during which the Prospectus is required by law to be delivered in connection therewith.
If during such period of time any event shall occur that in the judgment of the Company or counsel
to the Underwriters should be set forth in the Prospectus in order to make any statement therein,
in the light of the circumstances under which it was made, not misleading, or if it is necessary to
supplement or amend the Prospectus to comply with law, the Company shall forthwith prepare and duly
file with the Commission an appropriate supplement or amendment thereto, and shall deliver to each
of the Underwriters, without charge, such number of copies thereof as the Representative may
reasonably request. The Company shall not file any document under the Exchange Act before the
termination of the offering of the Shares by the Underwriters if such document would be deemed to
be incorporated by reference into the Prospectus unless a copy thereof shall first have been
submitted to the Representative within a reasonable period of time prior to the filing thereof and
the Representative shall not have objected thereto in good faith.
(g) Permitted Free Writing Prospectuses. The Company represents and agrees that it has not
made and, unless it obtains the prior consent of the Representative, will not make, any offer
relating to the Shares that would constitute a “free writing prospectus” as defined in Rule 405 of
the Rules and Regulations, required to be retained by the Company under Rule 433 of the Rules and
Regulations; provided that the prior written consent of the Representative hereto shall be deemed
to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule
III hereto. Any such free writing prospectus consented to by the Representative is herein
referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated
and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free
Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the
requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus,
including in respect of timely filing with the Commission, legending and record keeping.
(h) Compliance with Blue Sky Laws. Prior to any public offering of the Shares by the
Underwriters, the Company shall cooperate with the Representative and counsel to the Underwriters
in connection with the registration or qualification (or the obtaining of exemptions from the
application thereof) of the Shares for offer and sale under the securities or Blue Sky laws of such
jurisdictions as the Representative may request, including, without limitation, the provinces and
territories of Canada and other jurisdictions outside the United States; provided, however, that in
no event shall the Company be obligated to qualify to do business in any jurisdiction where it is
not now so qualified or to take any action which would subject it to general service of process in
any jurisdiction where it is not now so subject.
(i) Delivery of Financial Statements. During the period of five years commencing on the
effective date of the Registration Statement applicable to the Underwriters, the Company shall
furnish to the Representative and each other Underwriter who may so request copies of such
financial statements and other periodic and special reports as the Company may from time to time
distribute generally to the holders of any class of its capital stock, and will furnish to the
Representative and each other Underwriter who may so request a copy of each annual or other report
it shall be required to file with the Commission.
(j) Availability of Earnings Statements. The Company shall make generally available to
holders of its securities as soon as may be practicable but in no event later than the last day of
the fifteenth full calendar month following the calendar quarter in which the most recent effective
date occurs in accordance with Rule 158 of the Rules and Regulations, an earnings statement (which
need not be audited but shall be in reasonable detail) for a period of 12 months ended commencing
after the date hereof, and satisfying the provisions of Section 11(a) of the Act (including Rule
158 of the Rules and Regulations).
11
(k) Reimbursement of Certain Expenses. Whether or not any of the transactions contemplated by
this Agreement are consummated or this Agreement is terminated, the Company shall pay, or reimburse
if paid by the Representative, all costs and expenses incident to the performance of the
obligations of the Company under this Agreement, including but not limited to costs and expenses of
or relating to (i) the preparation, printing and filing of the Registration Statement and exhibits
to it, each preliminary prospectus, each Permitted Free Writing Prospectus, the Prospectus and any
amendment or supplement to the Registration Statement or the Prospectus, (ii) the preparation and
delivery of certificates representing the Shares, (iii) the printing of this Agreement, the
Agreement Among Underwriters, any Dealer Agreements and any Underwriters’ Questionnaire, (iv)
furnishing (including costs of shipping, mailing and courier) such copies of the Registration
Statement, the Prospectus, any preliminary prospectus and any Permitted Free Writing Prospectus,
and all amendments and supplements thereto, as may be requested for use in connection with the
offering and sale of the Shares by the Underwriters or by dealers to whom Shares may be sold, (v)
the listing or quotation of the Shares on the NASDAQ Global Select Market, (vi) any filings
required to be made by the Representative with FINRA, and the fees, disbursements and other charges
of counsel for the Underwriters in connection therewith, (vii) the registration or qualification of
the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions
designated pursuant to Section 4(h) hereof, including the fees, disbursements and other charges of
counsel to the Underwriters in connection therewith, and, if requested by the Representative, the
preparation and printing of preliminary, supplemental and final Blue Sky memoranda, (viii) counsel
to the Company, (ix) DTC and the transfer agent for the Shares, (x) the Accountants, (xi) the
marketing of the offering by the Company, including, without limitation, all costs and expenses of
commercial airline tickets, hotels, meals and other travel expenses of officers, employees, agents
and other representatives of the Company (but not officers, employees, agents or other
representatives of the Representative), (xii) all fees, costs and expenses for consultants used by
the Company in connection with the offering, and (xiii) fees, disbursements and other charges of
counsel to the Underwriters (in addition to (vi) and (vii) above) in an amount not to exceed
$100,000.
(l) Reimbursement of Expenses upon Termination of Agreement. If this Agreement shall be
terminated by the Company pursuant to any of the provisions hereof or if for any reason the
Company shall be unable to perform its obligations or to fulfill any conditions hereunder or if the
Underwriters shall terminate this Agreement pursuant to Section 7 or the Agreement is terminated
pursuant to the second sentence of Section 8, the Company shall reimburse the several Underwriters
for all out-of-pocket expenses (including the fees, disbursements and other charges of counsel to
the Underwriters) reasonably incurred by them in connection herewith; provided, however, that the
Company shall not be obligated to reimburse the expenses of any defaulting Underwriter under
Section 8.
(m) No Stabilization or Manipulation. The Company shall not at any time, directly or
indirectly, take any action intended to cause or result in, or which might reasonably be expected
to cause or result in, or which will constitute, stabilization or manipulation, under the Act or
otherwise, of the price of the shares of Common Stock to facilitate the sale or resale of any of
the Shares.
(n) Use of Proceeds. The Company shall apply the net proceeds from the offering and sale of
the Shares to be sold by the Company in the manner set forth in the Prospectus under “Use of
Proceeds”
(o) Lock-Up Agreements of Company, Management and Affiliates. The Company shall not, and
shall cause each of its executive officers and directors to enter into agreements with the
Representative in the form set forth in Exhibit A to the effect that they shall not, for a
period of 90 days after the date of the Prospectus (the “Lock-Up Period”), without the prior
written consent of BMOCM (which consent may be withheld in its sole discretion), (1) offer to sell,
sell, pledge, contract to sell, purchase any option to sell, grant any option for the purchase of,
lend, or otherwise dispose of, or require the Company to file with the Commission a registration
statement under the Act to register, any shares of Common Stock or any securities convertible into
or exercisable or exchangeable for Common Stock or warrants or other rights to acquire shares of
Common Stock of which they are now, or may in the future become, the beneficial owner (within the
meaning of Rule 13d-3 under the Exchange Act) (other than (A) the issuance of units in drilling
partnerships sponsored by the Company or Common Stock issued to acquire interests in outstanding
drilling partnerships sponsored by the Company or (B) pursuant to employee stock option plans or
Rule10b5-1 plans existing on, or upon the conversion or exchange of convertible or exchangeable
securities outstanding as of, the date of the Prospectus) or (2) enter into any swap or other
derivatives transaction that transfers to another, in whole or in part, any of the economic
benefits or risks of ownership of such shares of Common Stock, whether any such transaction
described in clause (1) or (2) above is to be settled by delivery of Common Stock or other
securities, in cash or otherwise; except that if (i) during the period that begins on the date
12
that is 15 calendar days plus three business days before the last day of the Lock-Up Period
and ends on the last day of the Lock-Up Period, the Company issues an earnings release or material
news or a material event relating to the Company occurs, or (ii) prior to the expiration of the
Lock-Up Period, the Company announces that it will release earnings results during the 16-day
period beginning on the last day of the Lock-Up Period, the restrictions imposed by this section
shall continue to apply until the expiration of the date that is 15 calendar days plus three
business days after the date on which the issuance of the earnings release or the material news or
material event occurs, provided, however, this provision will not apply if, within three days of
the termination of the Lock-Up Period, the Company delivers to BMOCM a certificate, signed by the
Chief Financial Officer or Chief Executive Officer of the Company, certifying on behalf of the
Company that the Company’s shares of Common Stock are, as of the date of delivery of such
certificate, “actively trading securities,” as defined in Regulation M under the Exchange Act.
5. Conditions of the Obligations of the Underwriters. The obligations of each
Underwriter hereunder are subject to the following conditions:
(a) Post Effective Amendments and Prospectus Filings. Notification that the Registration
Statement has become effective shall be received by the Representative not later than 6:00 p.m.,
New York City time, on the date of this Agreement or at such later date and time as shall be
consented to in writing by the Representative and all filings made pursuant to Rule 424 of the
Rules and Regulations and Rules 430A, 430B or 430C, as applicable, shall have been made or will be
made prior to the Closing Date in accordance with all such applicable rules.
(b) No Stop Orders, Requests for Information and No Amendments. (i) No stop order suspending
the effectiveness of the Registration Statement shall have been issued and no proceedings for that
purpose shall be pending or are, to the best knowledge of the Company, threatened by the
Commission, (ii) no order suspending the qualification or registration of the Shares under the
securities or Blue Sky laws of any jurisdiction shall be in effect and no proceeding for such
purpose shall be pending before or threatened or contemplated by the authorities of any such
jurisdiction, (iii) any request for additional information on the part of the staff of the
Commission or any such authorities shall have been complied with to the satisfaction of the staff
of the Commission or such authorities and (iv) after the date hereof no amendment or supplement to
the Registration Statement or the Prospectus shall have been filed unless a copy thereof was first
submitted to the Representative and the Representative did not object thereto in good faith, and
the Representative shall have received certificates, dated the Closing Date and signed by the Chief
Executive Officer or the Chairman of the Board of Directors and the Chief Financial Officer of the
Company (who may, as to proceedings threatened, rely upon the best of their information and
belief), to the effect of clauses (i), (ii) and (iii).
(c) No Material Adverse Changes. Since the respective dates as of which information is given
in the Registration Statement and the Prospectus, except as set forth or incorporated by reference
in the Prospectus (i) there shall not have been a Material Adverse Change, (ii) the Company shall
not have incurred any material liabilities or obligations, direct or contingent, (iii) the Company
shall not have entered into any material transactions not in the ordinary course of business other
than pursuant to this Agreement and the transactions referred to herein, (iv) the Company has not
issued any securities (other than the Shares) or declared or paid any dividend or made any
distribution in respect of its capital stock of any class or debt (long-term or short-term), and
(v) no material amount of the assets of the Company or any of the Subsidiaries shall have been
pledged, mortgaged or otherwise encumbered.
(d) No Actions, Suits or Proceedings. Since the respective dates as of which information is
given or incorporated by reference in the Registration Statement and the Prospectus, there shall
have been no actions, suits or proceedings instituted, or to the Company’s knowledge, threatened
against or affecting, the Company or the Subsidiaries or any of their respective officers in their
capacity as such, before or by any Federal, state or local court, commission, regulatory body,
administrative agency or other governmental body, domestic or foreign.
(e) All Representations True and Correct and All Conditions Fulfilled. Each of the
representations and warranties of the Company contained herein shall be true and correct in all
material respects at the Closing Date as if made at the Closing Date, and all covenants and
agreements contained herein to be performed by the Company and all conditions contained herein to
be fulfilled or complied with by the Company at or prior to the Closing Date, shall have been duly
performed, fulfilled or complied with.
13
(f) Opinion of Counsel to the Company. The Representative shall have received the opinion and
letter, each dated the Closing Date, reasonably satisfactory in form and substance to counsel for
the Underwriters, from Xxxxx & Xxxxxxxxxxx, counsel to the Company, to the effect set forth in
Exhibit B.
(g) Opinion of Counsel to the Underwriters. The Representative shall have received an
opinion, dated the Closing Date, from Xxxxxxxxxx Xxxxxxx PC, counsel to the Underwriters, with
respect to the Registration Statement, the Prospectus and this Agreement, which opinion shall be
satisfactory in all respects to the Representative.
(h) Accountants’ Comfort Letter. On the date of the Prospectus, the Representative shall have
received from the Accountants a letter dated the date of its delivery, addressed to the
Representative, in form and substance reasonably satisfactory to the Representative, containing
statements and information of the type ordinarily included in accountant’s “comfort letters” to
underwriters, delivered according to Statement of Auditing Standards No. 72 (or any successor
bulletin), with respect to the audited and unaudited financial statements and certain financial
information contained or incorporated by reference in the Registration Statement and the
Prospectus. At the Closing Date, the Representative shall have received from the Accountants a
letter dated such date, in form and substance reasonably satisfactory to the Representative, to the
effect that they reaffirm the statements made in the letter furnished by them pursuant to the
preceding sentence, except that the specified date referred to therein for the carrying out of
procedures shall be no more than three business days prior to the Closing Date.
(i) Officers’ Certificates. At the Closing Date, there shall be furnished to the
Representative an accurate certificate, dated the date of its delivery, signed by each of the Chief
Executive Officer and the Chief Financial Officer of the Company, in form and substance
satisfactory to the Representative, to the effect that:
(i) each signer of such certificate has carefully examined the Registration Statement and the
Prospectus (including any documents filed under the Exchange Act and deemed to be incorporated by
reference into the Prospectus);
(ii) there has not been a Material Adverse Change;
(iii) each of the representations and warranties of the Company contained in this Agreement
are, at the time such certificate is delivered, true and correct in all material respects; and
(iv) each of the covenants required herein to be performed by the Company on or prior to the
date of such certificate has been duly, timely and fully performed and each condition herein
required to be complied with by the Company on or prior to the delivery of such certificate has
been duly, timely and fully complied with.
(j) Lock-Up Agreements. On or prior to the Closing Date, the Representative shall have
received the executed “lock-up” agreements referred to in Section 4(o).
(k) Compliance with Blue Sky Laws. The Shares shall be qualified for sale in such states and
jurisdictions as the Representative may reasonably request, including, without limitation, the
provinces and territories of Canada and other jurisdictions outside the United States, and each
such qualification shall be in effect and not subject to any stop order or other proceeding on the
Closing Date.
(l) Stock Exchange Listing. The Shares shall have been duly authorized for listing or
quotation on the NASDAQ Global Select Market, subject only to notice of issuance.
(m) Company Certificates. The Company shall have furnished to the Representative such
certificates, in addition to those specifically mentioned herein, as the Representative may have
reasonably requested as to the accuracy and completeness at the Closing Date of any statement in
the Registration Statement or the Prospectus or any documents filed under the Exchange Act and
deemed to be incorporated by reference into the Prospectus, as to the accuracy at the Closing Date
of the representations and warranties of the Company herein, as to the performance by the Company
of its obligations hereunder, or as to the fulfillment of the conditions concurrent and precedent
to the obligations hereunder of the Representative.
14
6. Indemnification.
(a) Indemnification of the Underwriters. The Company shall indemnify and hold harmless each
Underwriter, the directors, officers, employees, counsel and agents of each Underwriter and each
person, if any, who controls each Underwriter within the meaning of Section 15 of the Act or
Section 20 of the Exchange Act from and against any and all losses, claims, liabilities, expenses
and damages (including any and all investigative, legal and other expenses reasonably incurred in
connection with, and any amount paid in settlement of, any action, suit or proceeding between any
of the indemnified parties and any indemnifying parties or between any indemnified party and any
third party, or otherwise, or any claim asserted), to which they, or any of them, may become
subject under the Act, the Exchange Act or other Federal or state statutory law or regulation, at
common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out
of or are based on (i) any untrue statement or alleged untrue statement of a material fact
contained in the Registration Statement (or any amendment thereto), including any information
deemed to be a part thereof pursuant to Rules 430A, 430B or 430C, as applicable, including all
documents incorporated therein by reference, or the omission or alleged omission therefrom of a
material fact required to be stated therein or necessary to make the statements therein not
misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in
any preliminary prospectus, any preliminary prospectus supplement, any Issuer Free Writing
Prospectus or the Prospectus (or any amendment or supplement thereto) or the omission or alleged
omission therefrom of a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading or (iii) any untrue statement
or alleged untrue statement of a material fact contained in any materials or information provided
to investors by, or with the approval of, the Company in connection with the marketing of the
offering of the Shares, including any roadshow or investor presentations made to investors by the
Company (whether in person or electronically) or the omission or alleged omission therefrom of a
material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however, that the Company shall not be liable
to the extent that such loss, claim, liability, expense or damage arises from the sale of the
Shares in the public offering to any person by an Underwriter and is based on an untrue statement
or omission or alleged untrue statement or omission made in reliance on and in conformity with
information relating to any Underwriter furnished in writing to the Company by the Representative
on behalf of any Underwriter expressly for inclusion in the Registration Statement, any preliminary
prospectus, any Issuer Free Writing Prospectus or the Prospectus. If multiple claims are brought
against any Underwriter, the directors, officers, employees, counsel and agents of such Underwriter
and any person, if any, who controls such Underwriter within the meaning of Section 15 of the Act
or Section 20 of the Exchange Act, in an arbitration proceeding, and indemnification is permitted
under applicable law and is provided for under this Agreement with respect to at least one such
claim, the Company agrees that any arbitration award shall be conclusively deemed to be based on
claims as to which indemnification is permitted and provided for, except to the extent the
arbitration award expressly states that the award, or any portion thereof, is based solely on a
claim as to which indemnification is not available. This indemnity agreement will be in addition
to any liability that the Compan
y might otherwise have.
(b) Indemnification of the Company. Each Underwriter, severally and not jointly, shall
indemnify and hold harmless the Company, its agents, each person, if any, who controls the Company
within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, each director of the
Company and each officer of the Company who signs the Registration Statement to the same extent as
the foregoing indemnity from the Company to each Underwriter, but only insofar as losses, claims,
liabilities, expenses or damages arise out of or are based on any untrue statement or omission or
alleged untrue statement or omission made in reliance on and in conformity with information
relating to each Underwriter furnished in writing to the Company by the Representative on behalf of
such Underwriter expressly for use in the Registration Statement, any preliminary prospectus or the
Prospectus. This indemnity will be in addition to any liability that each Underwriter might
otherwise have.
(c) Indemnification Procedures. Any party that proposes to assert the right to be indemnified
under this Section 6 shall, promptly after receipt of notice of commencement of any action against
such party in respect of which a claim is to be made against an indemnifying party or parties under
this Section 6, notify each such indemnifying party of the commencement of such action, enclosing a
copy of all papers served, but the omission so to notify such indemnifying party shall not relieve
the indemnifying party from any liability that it may have to any indemnified party under the
foregoing provisions of this Section 6 unless, and only to the extent that, such omission results
in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action
is brought against any indemnified party and it notifies the indemnifying party of its
commencement, the indemnifying party will be entitled to participate in and, to the extent that it
elects by delivering written notice to the indemnified party promptly after receiving notice of the
commencement of the action from the indemnified party,
15
jointly with any other indemnifying party similarly notified, to assume the defense of the
action, with counsel satisfactory to the indemnified party, and after notice from the indemnifying
party to the indemnified party of its election to assume the defense, the indemnifying party will
not be liable to the indemnified party for any legal or other expenses except as provided below and
except for the reasonable costs of investigation subsequently incurred by the indemnified party in
connection with the defense. The indemnified party will have the right to employ its own counsel
in any such action, but the fees, expenses and other charges of such counsel will be at the expense
of such indemnified party unless (i) the employment of counsel by the indemnified party has been
authorized in writing by the indemnifying party, (ii) the indemnified party has reasonably
concluded (based on advice of counsel) that there may be legal defenses available to it or other
indemnified parties that are different from or in addition to those available to the indemnifying
party, (iii) a conflict or potential conflict exists (based on advice of counsel to the indemnified
party) between the indemnified party and the indemnifying party (in which case the indemnifying
party shall not have the right to direct the defense of such action on behalf of the indemnified
party) or (iv) the indemnifying party has not in fact employed counsel to assume the defense of
such action within a reasonable time after receiving notice of the commencement of the action, in
each of which cases the reasonable fees, disbursements and other charges of counsel shall be at the
expense of the indemnifying party or parties. It is understood that the indemnifying party or
parties shall not, in connection with any proceeding or related proceedings in the same
jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one
separate firm admitted to practice in such jurisdiction at any one time for all such indemnified
party or parties. All such fees, disbursements and other charges shall be reimbursed by the
indemnifying party promptly as they are incurred. An indemnifying party shall not be liable for
any settlement of any action or claim effected without its written consent (which consent will not
be unreasonably withheld or delayed). No indemnifying party shall, without the prior written
consent of each indemnified party, settle or compromise or consent to the entry of any judgment in
any pending or threatened claim, action or proceeding relating to the matters contemplated by this
Section 6 (whether or not any indemnified party is a party thereto), unless such settlement,
compromise or consent includes an unconditional release of each indemnified party from all
liability arising or that may arise out of such claim, action or proceeding.
(d) Contribution. In order to provide for just and equitable contribution in circumstances in
which the indemnification provided for in the foregoing paragraphs of this Section 6 is applicable
in accordance with its terms but for any reason is held to be unavailable from the Company or the
Underwriters, the Company and the Underwriters shall contribute to the total losses, claims,
liabilities, expenses and damages (including any investigative, legal and other expenses reasonably
incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding
or any claim asserted, but after deducting any contribution received by the Company from persons
other than the Underwriters, such as persons who control the Company within the meaning of the Act,
officers of the Company who signed the Registration Statement and directors of the Company, who
also may be liable for contribution) to which the Company and the Underwriters may be subject in
such proportion as shall be appropriate to reflect the relative benefits received by the Company on
the one hand and the Underwriters on the other. The relative benefits received by the Company on
the one hand and the Underwriters on the other shall be deemed to be in the same proportion as the
total net proceeds from the offering (before deducting expenses) received by the Company bear to
the total underwriting discounts and commissions received by the Underwriters, in each case as set
forth in the table on the cover page of the Prospectus. If, but only if, the allocation provided
by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall
be made in such proportion as is appropriate to reflect not only the relative benefits referred to
in the foregoing sentence but also the relative fault of the Company, on the one hand, and the
Underwriters, on the other, with respect to the statements or omissions which resulted in such
loss, claim, liability, expense or damage, or action in respect thereof, as well as any other
relevant equitable considerations with respect to such offering. Such relative fault shall be
determined by reference to whether the untrue or alleged untrue statement of a material fact or
omission or alleged omission to state a material fact relates to information supplied by the
Company or Representative on behalf of the Underwriters, the intent of the parties and their
relative knowledge, access to information and opportunity to correct or prevent such statement or
omission. The Company and the Underwriters agree that it would not be just and equitable if
contributions pursuant to this Section 6(d) were to be determined by pro rata allocation or by any
other method of allocation (even if the Underwriters were treated as one entity for such purpose)
which does not take into account the equitable considerations referred to herein. The amount paid
or payable by an indemnified party as a result of the loss, claim, liability, expense or damage, or
action in respect thereof, referred to above in this Section 6(d) shall be deemed to include, for
purpose of this Section 6(d), any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim. Notwithstanding the
provisions of this Section 6(d), no Underwriter shall be required to contribute any amount in
excess of the underwriting discounts and commissions received by it, and no person found guilty of
fraudulent misrepresentation
16
(within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation. The Underwriters’ obligation to
contribute as provided in this Section 6(d) are several in proportion to their respective
underwriting obligations and not joint. For purposes of this Section 6(d), any person who controls
a party to this Agreement within the meaning of the Act will have the same rights to contribution
as that party, and each officer of the Company who signed the Registration Statement will have the
same rights to contribution as the Company, subject in each case to the provisions hereof. Any
party entitled to contribution, promptly after receipt of notice of commencement of any action
against such party in respect of which a claim for contribution may be made under this Section
6(d), will notify any such party or parties from whom contribution may be sought, but the omission
so to notify will not relieve the party or parties from whom contribution may be sought from any
other obligation it or they may have under this Section 6(d). No party will be liable for
contribution with respect to any action or claim settled without its written consent (which consent
will not be unreasonably withheld).
(e) Survival. The indemnity and contribution agreements contained in this Section 6 and the
representations and warranties of the Company contained in this Agreement shall remain operative
and in full force and effect regardless of (i) any investigation made by or on behalf of the
Underwriters, (ii) acceptance of any of the Shares and payment therefor or (iii) any termination of
this Agreement.
7. Termination. The obligations of the several Underwriters under this Agreement may
be terminated at any time prior to the Closing Date, by notice to the Company from the
Representative, without liability on the part of any Underwriter to the Company, if, prior to
delivery and payment for the Shares, in the sole judgment of the Representative, any of the
following shall occur:
(a) trading or quotation in any of the equity securities of the Company shall have been
suspended or limited by the Commission or by an exchange or otherwise;
(b) trading in securities generally on the New York Stock Exchange or the NASDAQ Global Select
Market shall have been suspended or limited or minimum or maximum prices shall have been generally
established on such exchange, or additional material governmental restrictions, not in force on the
date of this Agreement, shall have been imposed upon trading in securities generally by such
exchange or by order of the Commission or any court or other governmental authority;
(c) a general banking moratorium shall have been declared by any of Federal or New York
authorities;
(d) the United States shall have become engaged in new hostilities, there shall have been an
escalation in hostilities involving the United States or there shall have been a declaration of a
national emergency or war by the United States or there shall have occurred such a material adverse
change in general economic, political or financial conditions, including, without limitation, as a
result of terrorist activities after the date hereof (or the effect of international conditions on
the financial markets in the United States shall be such), or any other calamity or crisis shall
have occurred, the effect of any of which is such as to make it impracticable or inadvisable to
market the Shares on the terms and in the manner contemplated by the Prospectus;
(e) if the Company or any of its Subsidiaries shall have sustained a loss material or
substantial to the Company or any of its Subsidiaries by reason of flood, fire, accident,
hurricane, earthquake, theft, sabotage, or other calamity or malicious act, whether or not such
loss shall have been insured, the effect of any of which is such as to make it impracticable or
inadvisable to market the Shares on the terms and in the manner contemplated by the Prospectus; or
(f) if there shall have been a Material Adverse Change.
8. Substitution of Underwriters. If any one or more of the Underwriters shall fail or
refuse to purchase any of the Shares which it or they have agreed to purchase hereunder, and the
aggregate number of Shares which such defaulting Underwriter or Underwriters agreed but failed or
refused to purchase is not more than one-tenth of the aggregate number of Shares, the other
Underwriters shall be obligated, severally, to purchase the Shares which such defaulting
Underwriter or Underwriters agreed but failed or refused to purchase, in the proportions which the
number of Shares which they have respectively agreed to purchase pursuant to Section 1 bears to the
aggregate number of Shares which all such non-defaulting Underwriters have so agreed to purchase,
or in such other
17
proportions as the Representative may specify; provided that in no event shall the maximum
number of Shares which any Underwriter has become obligated to purchase pursuant to Section 1 be
increased pursuant to this Section 8 by more than one-ninth of the number of Shares agreed to be
purchased by such Underwriter without the prior written consent of such Underwriter. If any
Underwriter or Underwriters shall fail or refuse to purchase any Shares and the aggregate number of
Shares which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase
exceeds one-tenth of the aggregate number of the Shares and arrangements satisfactory to the
Company and the Representative for the purchase of such Shares are not made within 48 hours after
such default, this Agreement will terminate without liability on the part of any non-defaulting
Underwriter, or the Company (except as provided in Section 4(l)) for the purchase or sale of any
Shares under this Agreement. In any such case either the Representative or the Company shall have
the right to postpone the Closing Date, but in no event for longer than seven days, in order that
the required changes, if any, in the Registration Statement and in the Prospectus or in any other
documents or arrangements may be effected. Any action taken pursuant to this Section 8 shall not
relieve any defaulting Underwriter from liability in respect of any default of such Underwriter
under this Agreement.
9. Miscellaneous.
(a) Notices. Notice given pursuant to any of the provisions of this Agreement shall be in
writing and, unless otherwise specified, shall be mailed, hand delivered or telecopied (a) if to
the Company, at the office of the Company, 000 Xxxxxxxxxx Xxxxx, Xxxxx 000, Xxxxxxxxx, Xxxxxxxx
00000, Attention: Chief Executive Officer, with a copy to (which shall not constitute notice
hereunder): Xxxxx & Xxxxxxxxxxx, 000 Xxxxx Xxxxxx, Xxxxx 00X, Xxx Xxxx, Xxx Xxxx 00000, Attention:
Xxxxxxx Xxxxx, Esq., or (b) if to the Underwriters, at the offices of BMO Capital Markets Corp., 0
Xxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: Xxxxxx Xxxxxxx, with a copy to (which shall not
constitute notice hereunder): Xxxxxxxxxx Xxxxxxx PC, 0000 Xxxxxx xx xxx Xxxxxxxx, Xxx Xxxx, Xxx
Xxxx 00000. Attention: Xxxxxxx X. Xxxxxx, Esq. Any such notice shall be effective only upon
receipt. Any notice under Section 7 may be made by telecopy or telephone, but if so made shall be
subsequently confirmed in writing.
(b) No Third Party Beneficiaries. This Agreement has been and is made solely for the benefit
of the several Underwriters, the Company and of the controlling persons, directors and officers
referred to in Section 6, and their respective successors and assigns, and no other person shall
acquire or have any right under or by virtue of this Agreement. The term “successors and assigns”
as used in this Agreement shall not include a purchaser of Shares from the Underwriters in his,
her or its capacity as such a purchaser, as such purchaser of Shares from any of the several
Underwriters.
(c) Survival of Representations and Warranties. All representations, warranties and
agreements of the Company contained herein or in certificates or other instruments delivered
pursuant hereto, shall remain operative and in full force and effect regardless of any
investigation made by or on behalf of any Underwriter or any of their controlling persons and shall
survive delivery of and payment for the Shares hereunder.
(d) Disclaimer of Fiduciary Relationship. The Company acknowledges and agrees that (i) the
purchase and sale of the Shares pursuant to this Agreement, including the determination of the
public offering price of the Shares and any related discounts and commissions, is an arm’s-length
commercial transaction between the Company, on the one hand, and the Underwriters, on the other
hand, (ii) in connection with the offering contemplated by this Agreement and the process leading
to such transaction, each of the Underwriters is and has been acting solely as a principal and is
not the agent or fiduciary of the Company or its securityholders, creditors, employees or any
other party, (iii) none of the Underwriters has assumed nor will it assume any advisory or
fiduciary responsibility in favor of the Company with respect to the offering of the Shares
contemplated by this Agreement or the process leading thereto (irrespective of whether any
Underwriter or its affiliates has advised or is currently advising the Company on other matters)
and the Underwriters have no obligation to the Company with respect to the offering of the Shares
contemplated by this Agreement except the obligations expressly set forth in this Agreement, (iv)
each of the Underwriters and their respective affiliates may be engaged in a broad range of
transactions that involve interests that differ from those of the Company, and (v) the Underwriters
have not provided any legal, accounting, regulatory or tax advice with respect to the offering
contemplated by this Agreement and the Company has consulted its own legal, accounting, regulatory
and tax advisors to the extent it deemed appropriate.
18
(e) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY WITHIN
SUCH STATE. Each party hereto hereby irrevocably submits for purposes of any action arising from this Agreement brought by
the other party hereto to the jurisdiction of the courts of New York State located in the Borough
of Manhattan and the U.S. District Court for the Southern District of New York. This Agreement may
be signed in two or more counterparts with the same effect as if the signatures thereto and hereto
were upon the same instrument.
(f) Survival of Provisions Upon Invalidity of Any single Provision. In case any provision in
this Agreement shall be invalid, illegal or unenforceable, the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or impaired thereby.
(g) Waiver of Jury Trial. The Company and the Underwriters each hereby irrevocably waive any
right they may have to a trial by jury in respect of any claim based upon or arising out of this
Agreement or the transactions contemplated hereby.
(h) Titles and Subtitles. The titles of the sections and subsections of this Agreement are
for convenience and reference only and are not to be considered in construing this Agreement.
(i) Entire Agreement. This Agreement, together with that certain Engagement Letter dated
November 5, 2007, embodies the entire agreement and understanding between the parties hereto and
supersedes all prior agreements and understandings relating to the subject matter hereof. This
Agreement may not be amended or otherwise modified or any provision hereof waived except by an
instrument in writing signed by the Representative and the Company.
[Signature page follows]
19
Please confirm that the foregoing correctly sets forth the agreement among the Company and the
several Underwriters.
Very truly yours, NGAS RESOURCES, INC. |
||||
By: | ||||
Name: | Xxxxxxx X. Xxxx, III | |||
Title: | Vice President | |||
Confirmed as of the date first above mentioned:
BMO CAPITAL MARKETS CORP.
Acting on behalf of itself and as
Representative of the several Underwriters
named in Schedule I hereof
Representative of the several Underwriters
named in Schedule I hereof
By: | ||||
Name: | ||||
Title: | ||||
20